- Q1. What is the business of Rodec Pharma Limited?
It manufactures vet pharmaceuticals and animal feed supplements, serving livestock healthcare and nutrition needs across India. - Q2. Why is the company raising funds via IPO?
Rodec Pharma is raising funds via IPO to offer promoter-held shares to the public and gain listing benefits like visibility, liquidity, and future capital access. - Q3. What is the size of the issue and where will it list?
The issue size of the IPO is ~56.50 lakh shares entirely as offer-for-sale. It will be listed on the BSE & NSE platform. - Q4. What are the risks to an investor?
Risk factors include dependence on livestock demand cycles, regulatory/price controls, and limited fresh funds backing growth. - Q5. What are the potential upsides?
Upsides include strong niche focus in animal healthcare with a growing distribution footprint across many Indian states. - Q6. How to apply for the IPO?
You can apply for the IPO via ASBA through bank net banking, UPI on trading apps, or through your broker within the IPO subscription window once announced. - Q 7. When is the tentative listing date?
Expected listing date is yet to be announced.
Upcoming
Rodec Pharma Limited IPO: GMP today, Price, Review, Detail
0
IPO Score
0
*Score varies on actual price
Rodec Pharma Limited is a veterinary healthcare and animal nutrition company engaged in the manufacturing of animal feed supplements and the marketing of veterinary pharmaceutical drugs and feed supplements designed to address the healthcare and nutritional requirements of livestock animals, veterinarians, and animal healthcare providers.
Rodec Pharma Limited was incorporated in 1997 & currently Mr. Mukesh Kumar Gupta serves as the Managing Director of the company.
Rodec Pharma Limited filed its DRHP with SEBI on January 11, 2026. The IPO features entirely as an Offer for Sale of up to 56.50 lakh equity shares.
It offers veterinary pharmaceuticals and animal nutrition solutions including antibiotics, analgesics, anthelmintics, hormones, and feed supplements for livestock health.It operates through consignee agents, 400+ stockists and 400+ sales representatives across 15+ Indian states, serving veterinarians and livestock farmers nationwide.
Subscription date to apply for Rodec Pharma Limited is yet to be announced. Price band for the IPO is yet to be declared.
Revenue, PAT, EBITDA
Year |
2025 |
|---|---|
Networth
|
₹ 50.03 Cr
|
Revenue
|
₹ 106.39 Cr
|
EBITDA
|
₹ 25.76 Cr
|
PAT
|
₹ 18.25 Cr
|
EBITDA Margin
|
24.21%
|
PAT Margin
|
17.16%
|
Face Value
|
Rs.10 per Equity Share
|
IPO Important Dates
# |
Date |
|---|---|
Open Date
|
TBA
|
Close Date
|
TBA
|
Anchor Investor Bidding
|
TBA
|
Allotment Date
|
TBA
|
Refunds& Demat Credit
|
TBA
|
Tentative Listing Date
|
TBA
|
Use Of Proceeds
Purpose |
Amount |
|---|---|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
General Corporate Purpose
|
Balance
|
Financial Data
# |
2023 |
2024 |
2025 |
|---|---|---|---|
Revenue (₹ Cr)
|
₹ 71.6
|
₹ 88.4
|
₹ 106.4
|
PAT (₹ Cr)
|
₹ 5.2
|
₹ 11.0
|
₹ 18.3
|
Asset (₹ Cr)
|
₹ 44.1
|
₹ 50.6
|
₹ 72.0
|
Net Worth (₹ Cr)
|
₹ 20.7
|
₹ 31.7
|
₹ 50.0
|
IPO Grey Market Premium
Date |
IPO Price |
IPO GMP |
Profit Per Lot |
|---|---|---|---|
08-Aug
|
₹ –
|
₹ –
|
₹ –
|
07-Aug
|
₹ –
|
₹ –
|
₹ –
|
06-Aug
|
₹ –
|
₹ –
|
₹ –
|
05-Aug
|
₹ –
|
₹ –
|
₹ –
|
04-Aug
|
₹ –
|
₹ –
|
₹ –
|
Promoters – Pre offer equity (Approx)
Promoters |
% Shares |
|---|---|
Mukesh Kumar Gupta
|
51.38%
|
Chhaya Gupta
|
25.19%
|
Utkarsh Gupta
|
13.61%
|
-
|
-
|
-
|
-
|
-
|
-
|
Lot Size details
Application Type |
Lot Size |
No. of Lot |
No. of Shares |
Investment Amount |
|---|---|---|---|---|
Retail (Min)
|
–
|
1
|
–
|
₹ –
|
Retail (Max)
|
–
|
13
|
–
|
₹ –
|
HNI (Min)
|
–
|
14
|
–
|
₹ –
|
HNI (Max)
|
–
|
66
|
–
|
₹ –
|
Big HNI (Min)
|
–
|
67
|
–
|
₹ –
|
Key Performance Index (KPI)
ROE |
36.49% |
|---|---|
ROCE
|
40.94%
|
RoNW
|
36.49%
|
JOIN OUR SOCIAL-MEDIA PLATFORMS TO STAY UPDATED
